Discover and read the best of Twitter Threads about #truvada
Most recents (4)
#Timely as I discuss #Truvada for the prevention of HIV and hopefully, relief from chronic SARS-Cov-2 infections. cell.com/the-innovation…
I was tagged in a post a number of times and thought that I would do a little 🧵. Several months ago, I began to observe the similarities between the pathophysiology of a chronic HIV and SARS-Cov-2 infection.
It was at that time that I performed a great deal of study into molecular docking studies involving Gilead's portfolio. They are the largest manufacturer of first line HIV medications in the country. I didn't fool with Pfizer because they make salvage drugs, lol.
#LongCovid #Truvada #PorscheVsPinto #DoubleNukeIt
@BradyDale311 was kind enough to send over a journal article that just hit the news today and it appears to offer a great deal of promise. aidsmap.com/news/oct-2022/…
@BradyDale311 was kind enough to send over a journal article that just hit the news today and it appears to offer a great deal of promise. aidsmap.com/news/oct-2022/…
@BradyDale311 As someone intimately familiar with the concepts of reservoir seeding, estimated date of seroconversion, and one who has observed haunting parallels between the pathophysiology of chronic HIV and SARS-Cov-2 infections, I knew repurposing was necessary and have written about it.
@BradyDale311 Molecular docking studies have proven that a number of first line HIV antivirals proved the ability to do so. While there have been studies investigating the use of Truvada as PreP and treatment, the results have been mixed.
Fred Hutch scientists are hailing “a true milestone” in last week’s FDA approval of the world’s first long-acting, injectable drug that can prevent HIV infection—as much as 90% more effective than taking a daily pill. bit.ly/3FOSWiF 1/9
Hutch biostatistician Dr. Deborah Donnell said this means “we now have a safe alternative to taking daily HIV prevention pills” like #Truvada, which already is nearly 100% effective—but only if you always remember to take your pills. bit.ly/3mCgEqs 2/9
“We think it could make a really big difference until we have a cure or a vaccine,” says Donnell, head of the data center that analyzed for (NC-based) @HIVptn results from its 2 key trials that proved the injectable drug, cabotegravir, worked well. bit.ly/3qx3z2O 3/9
[LT] A 17 h suivez en direct la webconférence "VIH et COVID-19 : Avancées et Incertitudes" avec Dr Jade Ghosn (Paris), Dr Gilles Peytavin (Paris), Pr François Raffi (Nantes)
webconfaei.com/vih-covid.asp
webconfaei.com/vih-covid.asp
François Raffin introduit la séance en évoquant les nombreuses avancées thérapeutiques. Il n'y a pas de sur-représentation des patients VIH parmi les personnes atteintes par la COVID-19.
Les pistes thérapeutiques sont représentées par les antiviraux mais aussi par les stéroïdes et les interleukines (corrigez moi si je me trompe).
